Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » News » Senate moves motion to establish rare cancer inquiry

Senate moves motion to establish rare cancer inquiry

  • June 26, 2023

Senator, Wendy Askew has moved a motion to conduct a Senate Inquiry regarding Equitable Access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer. 

The Terms of Reference for the inquiry are:

Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer, with particular reference to:

a. barriers to screening and diagnosis, including the impact of factors such as:

i. geographic location,
ii. cost,
iii. cultural and language barriers,
iv. type of cancer, and
v. availability of treating practitioners;

b. barriers to accessing appropriate treatment;

c. the adequacy of support services after diagnosis;

d. the adequacy of Commonwealth funding for research into rare, less common, and neuroendocrine cancer; and

e. any other related matters.

You can read Senator Wendy Askew’s full press release HERE.

If you have experienced any of these factors and would like to help support this landmark inquiry please register your details below and we will be in touch shortly with a template and further instructions to assist in your submission.

Register your details below

Share this post

Recent posts

Sydney NET Patient Forum Brings Together Patients and Clinicians

October 28, 2025

Patient and Consumer Roundtable on Comparator Selection in HTA

October 27, 2025

Racing for a Cure 2025

October 27, 2025

NECA Highlights Gaps in Government’s Senate Inquiry Response

October 16, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousGlobal Gaps in Access to Diagnostics and Treatment for Neuroendocrine Cancer Patients published in Journal of Neuroendocrinology
NextEquitable access for all NET patientsNext

Related Posts

Patient and Consumer Roundtable on Comparator Selection in HTA

On Monday 27 October our CEO attended a face to face Patient and Consumer Roundtable in Canberra with 10 other not-for-profit organisation. The Roundtable was

Racing for a Cure 2025

On Friday 24 October, the Flinders Island community once again rallied behind Rob Hammond and Racing for a Cure for its fourth consecutive year, delivering

NECA Highlights Gaps in Government’s Senate Inquiry Response

After 458 days of waiting, the Government finally released its response to the Senate  Inquiry into Rare and Less Common Cancers, including Neuroendocrine Cancer, on

Rare Cancers Roundtable

NECA recently attended a Rare Cancers Roundtable to discuss “The value of cancer clinical trials and setting up for success.” Attendees were diverse, including industry,

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin